Effect of rituximab in refractory SLE: Inhibition of Th1? (multiple letters) [9]

Rheumatology

Volumn 45, Issue 1, 2006, Pages 121-123

  Okamoto, H ^a   Tanaka, Y ^b   Tokunaga, M ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LEUKOCYTE ANTIGEN; LIGAND; RITUXIMAB;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL INTERACTION; CELL LINEAGE; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFECTION COMPLICATION; LETTER; LYMPHOCYTE DEPLETION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTIGENS, CD40; B-LYMPHOCYTES; DOWN-REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TH1 CELLS;

EID: 29844451692     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei188     Document Type: Letter

References (0)